Title: Role of Intravenous Glutathione in Alcoholic Hepatitis
Authors: Dr Tamphasana Wairokpam, Dr. Robinson Ningshen, Dr. Jafar Niyas, Dr. Nungsa
DOI: https://dx.doi.org/10.18535/jmscr/v5i3.101
Abstract
It has been studied and documented that in alcoholic hepatitis and other chronic liver diseases, there is a reduction in hepatocyte glutathione level resulting in reduction of hepatocyte detoxifying action. The administration of high doses of intravenous (iv) glutathione in such patient population has demonstrated a significant improvement in some indices of liver function (SGOT, SGPT, GTT), suggesting the use of glutathione in alcoholic hepatitis.
Keywords: alcoholic hepatitis, glutathione, hepatic steatosis, hepatocellular Ca.
1. Yoon Y, Yi H. Liver cirrhosis mortality in the United States, 1970-2007 surveillancereport#88. NIAAA homepage.2010 Available at: http://pubs.niaaa.nih.gov/publications/surveillance88/Cirr07.htm
2. Lieber CS. Susceptibility to alcohol-related liver injury. Alcohol Alcohol Suppl. 1994;2:315-26
3. Schuckit MA. Alcohol and Alcoholism. In: Kasper DL, Braunwald E, Fauci AS, Hauser, Longo DL, Jameson JL, editors. Harrison’s principle of internal medicine. Vol 2. 17th ed. Newyork: Mc Graw Hill; 2008. P 2724-729.
4. Setshedi M, Wands JR, Monte SM. Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev. 2010;3(3):178-85
5. Robert S. O’Shea, Srinivasan Dasarathy, Arthur J. McCullough. AASLD PRACTICE GUIDELINES Alcoholic Liver Disease. 2010 Available at: http://www.aasld.org/sites/default/files/guideline_documents/AlcoholicLiverDisease1-2010.pdf
6. Dentico P1, Volpe A, Buongiorno R, Grattagliano I, Altomare E, Tantimonaco G, et al. Glutathione in the treatment of chronic fatty liver diseases. Recenti Prog Med. 1995;86(7):290-3.
7. De Groote, J., and Vandenbroucke, J. Glutathione in hepatitis. Acta gastroenter. Belg. 1956; 19:97-104
8. Helbeig, G. Behavior and clinical significance of SH Glutathion in various hepatopathies. Clinical Part. Z. Children's health 1954;74:622-634.
